Itoyama Y, Minato S, Goto I, Okochi K, Yamamoto N
Department of Neurology, Kyushu University, Fukuoka, Japan.
Neurology. 1988 Oct;38(10):1650-3. doi: 10.1212/wnl.38.10.1650.
We studied the serum antibody titers to Epstein-Barr virus (EBV) in 11 patients with HTLV-I-associated myelopathy (HAM). HAM patients showed significant increases in IgG antibodies to EBV-capsid antigen (VCA) and -early antigen (EA) and in VCA-specific IgA compared with 25 seronegative subjects. However, there were no significant differences in antibodies to EBV-nuclear antigen (EBNA) or to other viruses between the two groups. In HAM patients, altered antibody responses occurred specifically to EBV-associated antigens, not to other viruses.
我们研究了11例成人T细胞白血病病毒I型相关脊髓病(HAM)患者的血清抗Epstein-Barr病毒(EBV)抗体滴度。与25名血清阴性受试者相比,HAM患者的EBV衣壳抗原(VCA)和早期抗原(EA)的IgG抗体以及VCA特异性IgA显著增加。然而,两组之间EBV核抗原(EBNA)或其他病毒的抗体没有显著差异。在HAM患者中,抗体反应的改变是特异性针对EBV相关抗原的,而非其他病毒。